1. Home
  2. MNPR vs BCML Comparison

MNPR vs BCML Comparison

Compare MNPR & BCML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNPR
  • BCML
  • Stock Information
  • Founded
  • MNPR 2014
  • BCML 2004
  • Country
  • MNPR United States
  • BCML United States
  • Employees
  • MNPR N/A
  • BCML N/A
  • Industry
  • MNPR Biotechnology: Pharmaceutical Preparations
  • BCML Major Banks
  • Sector
  • MNPR Health Care
  • BCML Finance
  • Exchange
  • MNPR Nasdaq
  • BCML Nasdaq
  • Market Cap
  • MNPR 250.0M
  • BCML 295.7M
  • IPO Year
  • MNPR 2019
  • BCML N/A
  • Fundamental
  • Price
  • MNPR $40.25
  • BCML $27.65
  • Analyst Decision
  • MNPR Strong Buy
  • BCML
  • Analyst Count
  • MNPR 4
  • BCML 0
  • Target Price
  • MNPR $43.00
  • BCML N/A
  • AVG Volume (30 Days)
  • MNPR 71.2K
  • BCML 20.5K
  • Earning Date
  • MNPR 03-27-2025
  • BCML 04-17-2025
  • Dividend Yield
  • MNPR N/A
  • BCML 1.99%
  • EPS Growth
  • MNPR N/A
  • BCML N/A
  • EPS
  • MNPR N/A
  • BCML 2.10
  • Revenue
  • MNPR N/A
  • BCML $96,253,000.00
  • Revenue This Year
  • MNPR N/A
  • BCML N/A
  • Revenue Next Year
  • MNPR N/A
  • BCML $6.08
  • P/E Ratio
  • MNPR N/A
  • BCML $13.19
  • Revenue Growth
  • MNPR N/A
  • BCML N/A
  • 52 Week Low
  • MNPR $1.72
  • BCML $18.54
  • 52 Week High
  • MNPR $54.30
  • BCML $30.13
  • Technical
  • Relative Strength Index (RSI)
  • MNPR 49.34
  • BCML 47.49
  • Support Level
  • MNPR $38.80
  • BCML $27.52
  • Resistance Level
  • MNPR $45.60
  • BCML $28.56
  • Average True Range (ATR)
  • MNPR 5.19
  • BCML 0.78
  • MACD
  • MNPR -1.50
  • BCML -0.12
  • Stochastic Oscillator
  • MNPR 9.37
  • BCML 13.74

About MNPR Monopar Therapeutics Inc.

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin for the treatment of soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.

About BCML BayCom Corp

BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services.

Share on Social Networks: